MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia
Background: Micro (mi)RNAs play an important role in the pathogenesis and development of acute myeloid leukemia (AML), and their abnormal expression may be sufficient to predict the prognosis and outcomes in AML patients. We evaluated the clinical diagnostic value of miRNA-181a-3p in predicting prog...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2020-02-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/4012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846147069348151296 |
|---|---|
| author | Xiaoling Ma |
| author_facet | Xiaoling Ma |
| author_sort | Xiaoling Ma |
| collection | DOAJ |
| description | Background: Micro (mi)RNAs play an important role in the pathogenesis and development of acute myeloid leukemia (AML), and their abnormal expression may be sufficient to predict the prognosis and outcomes in AML patients. We evaluated the clinical diagnostic value of miRNA-181a-3p in predicting prognosis and outcomes in patients with AML.
Methods: A total of 119 newly diagnosed adult patients with AML and 60 healthy controls were recruited. Blood specimens were obtained from all AML patients at diagnosis, and 10 blood specimens were obtained on day 28 after induction chemotherapy. The controls also provided blood samples. MiR-181a-3p expression was quantified by PCR, and relative miRNA expression was determined using the comparative Ct method.
Results: Compared with healthy controls, the expression of miRNA-181a-3p was significantly increased in patients with AML. MiR-181a-3p expression could be used to discriminate AML patients from controls, with up-regulated expression correlating with favorable prognosis. Moreover, miRNA-181a-3p expression was significantly decreased in patients who achieved a complete response after induction chemotherapy. The multivariate Cox analysis highlighted the prognostic value of miR-181a-3p for patients with AML.
Conclusions: MiR-181a-3p may be clinically useful as a disease marker for AML, and enhanced the prediction of patient outcomes to chemotherapy. |
| format | Article |
| id | doaj-art-e5611ee6e44f46abbea00f8270588cf2 |
| institution | Kabale University |
| issn | 2035-3006 |
| language | English |
| publishDate | 2020-02-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-e5611ee6e44f46abbea00f8270588cf22024-12-02T00:01:59ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062020-02-0112110.4084/mjhid.2020.012MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemiaXiaoling Ma0Shandong UniversityBackground: Micro (mi)RNAs play an important role in the pathogenesis and development of acute myeloid leukemia (AML), and their abnormal expression may be sufficient to predict the prognosis and outcomes in AML patients. We evaluated the clinical diagnostic value of miRNA-181a-3p in predicting prognosis and outcomes in patients with AML. Methods: A total of 119 newly diagnosed adult patients with AML and 60 healthy controls were recruited. Blood specimens were obtained from all AML patients at diagnosis, and 10 blood specimens were obtained on day 28 after induction chemotherapy. The controls also provided blood samples. MiR-181a-3p expression was quantified by PCR, and relative miRNA expression was determined using the comparative Ct method. Results: Compared with healthy controls, the expression of miRNA-181a-3p was significantly increased in patients with AML. MiR-181a-3p expression could be used to discriminate AML patients from controls, with up-regulated expression correlating with favorable prognosis. Moreover, miRNA-181a-3p expression was significantly decreased in patients who achieved a complete response after induction chemotherapy. The multivariate Cox analysis highlighted the prognostic value of miR-181a-3p for patients with AML. Conclusions: MiR-181a-3p may be clinically useful as a disease marker for AML, and enhanced the prediction of patient outcomes to chemotherapy.http://www.mjhid.org/index.php/mjhid/article/view/4012MicroRNAs; MiR-181a-3p; biomarkers; Leukemia, Myeloid, Acute; Treatment Outcome |
| spellingShingle | Xiaoling Ma MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia Mediterranean Journal of Hematology and Infectious Diseases MicroRNAs; MiR-181a-3p; biomarkers; Leukemia, Myeloid, Acute; Treatment Outcome |
| title | MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia |
| title_full | MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia |
| title_fullStr | MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia |
| title_full_unstemmed | MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia |
| title_short | MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia |
| title_sort | microrna 181a 3p as a diagnostic and prognostic biomarker for acute myeloid leukemia |
| topic | MicroRNAs; MiR-181a-3p; biomarkers; Leukemia, Myeloid, Acute; Treatment Outcome |
| url | http://www.mjhid.org/index.php/mjhid/article/view/4012 |
| work_keys_str_mv | AT xiaolingma microrna181a3pasadiagnosticandprognosticbiomarkerforacutemyeloidleukemia |